Terms: = Breast cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
120 results:
1. Deubiquitinase BRCC3 promotes the migration, invasion and emt progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract] [Full Text] [Related]
2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer.
Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A
Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470
[TBL] [Abstract] [Full Text] [Related]
5. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract] [Full Text] [Related]
7.
Shakartalla SB; Ashmawy NS; Semreen MH; Fayed B; Al Shareef ZM; Jayakumar MN; Ibrahim S; Rahmani M; Hamdy R; Soliman SSM
Sci Rep; 2024 Jan; 14(1):253. PubMed ID: 38167685
[TBL] [Abstract] [Full Text] [Related]
8. Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy.
Zhou X; Jia Y; Mao C; Liu S
Cancer Lett; 2024 Jan; 580():216481. PubMed ID: 37972701
[TBL] [Abstract] [Full Text] [Related]
9. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
Deng Y; Dong Y; Wu L; Zhang Q; Yang L
Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer genetic analysis of disulfidptosis-related gene set.
Liu H; Tang T
Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
[TBL] [Abstract] [Full Text] [Related]
11. Tumor dormancy: emt beyond invasion and metastasis.
Aouad P; Quinn HM; Berger A; Brisken C
Genesis; 2024 Feb; 62(1):e23552. PubMed ID: 37776086
[TBL] [Abstract] [Full Text] [Related]
12. A Pan-cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3.
Xu Q; Wang J; Wang J; Zhu Y; Chen B; Guo R; Qian Y; Yuan H; Liu F
Crit Rev Eukaryot Gene Expr; 2023; 33(8):57-75. PubMed ID: 37606164
[TBL] [Abstract] [Full Text] [Related]
13. MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer.
Pan L; Liu W; Zhao H; Chen B; Yue X
Technol Health Care; 2023; 31(6):2251-2265. PubMed ID: 37545272
[TBL] [Abstract] [Full Text] [Related]
14. CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis.
Ma J; Chen C; Fan Z; Zhang Y; Ji J; Wei D; Zhang F; Sun B; Huang P; Ren L
Int J Biol Macromol; 2023 Jul; 244():125295. PubMed ID: 37302631
[TBL] [Abstract] [Full Text] [Related]
15. Role of glycosylation in breast cancer progression and metastasis: implications for miRNA, emt and multidrug resistance.
Gupta R; Ponangi R; Indresh KG
Glycobiology; 2023 Aug; 33(7):545-555. PubMed ID: 37283470
[TBL] [Abstract] [Full Text] [Related]
16. RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity.
Kuang J; Duan T; Gao C; Liu C; Chen S; Zhu LY; Min L; Lu C; Wang W; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(4):661-671. PubMed ID: 37154586
[TBL] [Abstract] [Full Text] [Related]
17. ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies.
Yang S; Wang X; Zhou X; Hou L; Wu J; Zhang W; Li H; Gao C; Sun C
Biomed Pharmacother; 2023 Jun; 162():114698. PubMed ID: 37060661
[TBL] [Abstract] [Full Text] [Related]
18. PCB: A pseudotemporal causality-based Bayesian approach to identify emt-associated regulatory relationships of AS events and RBPs during breast cancer progression.
Sun L; Qiu Y; Ching WK; Zhao P; Zou Q
PLoS Comput Biol; 2023 Mar; 19(3):e1010939. PubMed ID: 36930678
[TBL] [Abstract] [Full Text] [Related]
19. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Huang SC; Huang CC; Ko CY; Huang CY; Liu CH; Lee YK; Chen TY; Hsueh CW; Tzou SJ; Tai MH; Hu TH; Tsai MC; Lee WC; Ho YC; Wu CC; Chang YC; Chang JJ; Liu KH; Li CC; Wen ZH; Chang CL; Chu TH
Gene; 2023 May; 865():147331. PubMed ID: 36871674
[TBL] [Abstract] [Full Text] [Related]
20. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative breast cancer.
Banerjee M; Rajeswari VD
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838790
[TBL] [Abstract] [Full Text] [Related]
[Next]
